Abstract
Immune checkpoint inhibitor (ICI) colitis is among the most prevalent immune-related adverse events (irAEs) of immune checkpoint blockade (ICB). Deeper pathophysiological understanding can contribute to evidence-based management of ICI colitis. While single-cell RNA sequencing studies lack tissue architectural insight, we used imaging mass cytometry (IMC) to study ICI colitis spatially in high immunological detail.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.